← FDA Drug Approvals (Drugs@FDA)

DOXAZOSIN MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2022-03-15

Drug application

FDA Application #

ANDA212727

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXAZOSIN MESYLATE

Generic name

DOXAZOSIN

Active ingredients

DOXAZOSIN MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RISING

Manufacturer

Rising Pharma Holdings, Inc.

First approval

2022-03-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown